Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temodar in Adults With Brain Metastases
NCT00005954Phase 2Completed
- Sponsor
- Duke University
- Start
- Aug 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of temozolomide in brain metastases, sponsored by Duke University. Primary endpoints: Activity of Temozolomide and Toxicity of Treatment. Started Aug 2000; status: completed.
02
Drugs
temozolomide
03
Conditions
brain metastases
Beyond the preview
Go deeper on NCT00005954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005954.